Beckman Coulter is a leading supplier of pathology analysers and test kits. The Prostate Health Index (PHI) is a blood test that provides superior indications to discriminate prostate cancer from benign prostatic disease. It is a non-invasive option that has been shown in some settings to avoid 20% of prostate biopsies
London Agency worked with Beckman Coulter and Key Opinion Leaders to increase awareness of PHI, build adoption among pathology providers and awareness from General Practitioners and consumers. Using media relations to build test awareness and adoption from laboratories and build education among General Practitioners. London Agency developed storylines, media releases and video content around the proven opportunities that this test could unlock in Australia. London Agency organised media, articles and videos featuring leading Australian and American Urologists as well as interviews with Chemical Pathologists.
